研究者業績

仲矢 丈雄

ナカヤ タケオ  (Takeo Nakaya)

基本情報

所属
自治医科大学 医学部病理学講座 人体病理学部門 准教授
学位
博士(医学)(東京大学)

研究者番号
80512277
J-GLOBAL ID
201501007018614597
researchmap会員ID
B000247321

外部リンク

2015年4月~ 自治医科大学 医学部・大学院医学研究科 講師

論文

 37
  • Kentaro Tsuji, Hirotoshi Kawata, Tomoko Kamiakito, Takeo Nakaya, Akira Tanaka
    The Journal of steroid biochemistry and molecular biology 235 106407-106407 2023年10月6日  
    Castration-resistant prostate cancer (CRPC) is a big challenge in managing prostate cancer patients. The androgen receptor (AR) pathway is a major driver even in CRPC under androgen deprivation. The mechanism in maintaining of the AR pathway under androgen deprivation remains elusive. The recent discovery of biomolecular condensate, a membrane-less intracellular construct formed by liquid-liquid phase separation (LLPS), that facilitate molecular assembly, encouraged the re-screening of our previous microarray data list. We selected Rbm14 as a target molecule for further analysis because it works as a coactivator of nuclear receptors as well as it facilitates formation of biomolecular condensates via its intrinsically disordered region. GFP-tagged Rbm14 transfected into HEK293T cells formed droplet-like puncta, which diminished following treatment with 1,6-hexanediol. Droplet-like structures were also observed in immunofluorescence for endogenous RBM14 of PC-3 and DU145 cells. Luciferase assay revealed that Rbm14 enhanced androgen-responsive element (ARE)-mediated reporter activity in all conditions with or without testosterone and AR. Co-immunoprecipitation confirmed the Rbm14-AR interaction. Long non-coding RNAs, including NEAT1, SRA1, and HOTAIR, were also interacted with Rbm14. Small interfering RNAs of NEAT1 reduced ARE-mediated reporter activity, while transfection of SRA1 and HOTAIR enhance the reporter activity. Treatment with 1,6-hexanediol as well as transfection with a dominant-negative splice variant of Rbm14 reduced expression of prostate specific antigen (PSA), a prototype of androgen-regulated gene, in LNCaP, PC-3, and DU145 cells under androgen deprivation. Immunohistochemically, RBM14 expression was substantially upregulated in prostate cancer tissues after androgen deprivation therapy than in untreated tumors. In conclusion, RBM14 is a novel factor involved in maintenance of PSA expression via phase separation under androgen deprivation in prostate cancer.
  • Kiyokuni Tanabe, Kensuke Yokoyama, Atsushi Kanno, Eriko Ikeda, Kozue Ando, Hiroki Nagai, Takahiro Koyanagi, Mio Sakaguchi, Takeo Nakaya, Kiichi Tamada, Toshiro Niki, Noriyoshi Fukushima, Alan Kawarai Lefor, Hironori Yamamoto
    Internal medicine (Tokyo, Japan) 2023年8月2日  
    A 61-year-old woman was administered 35 cycles of pembrolizumab for the treatment of recurrent endometrial cancer, achieving a complete response. She presented with asymptomatic pancreatic enlargement and elevated hepatobiliary enzymes, but amylase and lipase levels were within the normal ranges. Intrapancreatic bile duct stenosis due to pancreatic enlargement was present, mimicking autoimmune pancreatitis on computed tomography performed before the onset of clinical manifestations. A histological examination of a biopsy specimen showed lymphocyte and plasma cell infiltration with dense fibrosis in the stroma. The patient was successfully treated with oral prednisolone. There were no manifestations of recurrent pancreatitis after tapering the prednisolone dose.
  • Yuma Horii, Shoichi Matsuda, Chikashi Toyota, Takumi Morinaga, Takeo Nakaya, Soken Tsuchiya, Masaki Ohmuraya, Takanori Hironaka, Ryo Yoshiki, Kotaro Kasai, Yuto Yamauchi, Noburo Takizawa, Akiomi Nagasaka, Akira Tanaka, Hidetaka Kosako, Michio Nakaya
    Nature Communications 14(1) 2023年2月8日  
    Abstract Myofibroblasts cause tissue fibrosis by producing extracellular matrix proteins, such as collagens. Humoral factors like TGF-β, and matrix stiffness are important for collagen production by myofibroblasts. However, the molecular mechanisms regulating their ability to produce collagen remain poorly characterised. Here, we show that vestigial-like family member 3 (VGLL3) is specifically expressed in myofibroblasts from mouse and human fibrotic hearts and promotes collagen production. Further, substrate stiffness triggers VGLL3 translocation into the nucleus through the integrin β1-Rho-actin pathway. In the nucleus, VGLL3 undergoes liquid-liquid phase separation via its low-complexity domain and is incorporated into non-paraspeckle NONO condensates containing EWS RNA-binding protein 1 (EWSR1). VGLL3 binds EWSR1 and suppresses miR-29b, which targets collagen mRNA. Consistently, cardiac fibrosis after myocardial infarction is significantly attenuated in Vgll3-deficient mice, with increased miR-29b expression. Overall, our results reveal an unrecognised VGLL3-mediated pathway that controls myofibroblasts’ collagen production, representing a novel therapeutic target for tissue fibrosis.
  • 仲矢 丈雄, 相澤 健一, 田口 由起, 辻 賢太郎, 關根 沙知, 村上 知弘, 近藤 恭光, 旦 慎吾, 吉森 篤史, 小路 弘行, 竹原 大, 鈴木 亨, 長田 裕之, 村田 昌之, 田中 亨, 永井 良三
    日本癌学会総会記事 81回 S10-6 2022年9月  
  • Hiroka Iwata, Koji Kamiya, Soichiro Kado, Takeo Nakaya, Hirotoshi Kawata, Mayumi Komine, Mamitaro Ohtsuki
    The Journal of dermatology 48(12) e598-e599 2021年12月  
  • Takeo Nakaya, Koji Kamiya, Michio Nakaya, Kentaro Tsuji, Toshiro Niki, Mamitaro Ohtsuki, Akira Tanaka
    Medicine 99(29) e20867 2020年7月17日  査読有り
    RATIONALE: Phagocytosis is an important physiological process for eliminating unnecessary substances or dead cells after tissue damage, such as inflammation or infarction. Phagocytosis was previously considered to be mainly performed by professional phagocytotic cells, such as macrophages. In contrast, we previously demonstrated that the phagocytosis of dead cells and unnecessary substances by myofibroblasts is as important as that by professional phagocytotic cells in myocardial infarction. Based on our discovery, we speculated that phagocytosis by myofibroblasts may be a more common pathological phenomenon also in other diseases than previously believed. PATIENT CONCERNS: A 44-year-old male patient with atopic dermatitis developed a cutaneous reddish nodule with an underlying induration on his thigh. INTERVENTIONS: The cutaneous lesion was surgically removed. DIAGNOSES: Histopathological examination demonstrated that the cutaneous lesion had solid infiltration by inflammatory cells, namely, plasma cells, histiocytes, and lymphocytes, in the dermis. The cutaneous lesion included mucinosis in the dermis. Inside the mucinosis, we detected cells with clear areas of mucinous substances. Some of the cells were α-smooth muscle actin-positive myofibroblasts. Electron microscopic images demonstrated that there were collagen bands in the cells with mucinous engulfment. Based on these pieces of evidence, we conclude that these mucinous phagocytotic cells were myofibroblasts, not professional phagocytotic cells, such as macrophages. OUTCOMES: There was no recurrence of the lesion. LESSONS: The clinical appearance of this case resembled that of previously reported solitary cutaneous focal mucinoses. However, our case had distinctive characteristics, such as the phagocytosis of mucinous substances by myofibroblasts, multiple mucinous lesions in a single eruption, and the presence of inflammatory cells, which have not been previously reported. For this distinct cutaneous lesion, a clear dermatological and pathological name has yet to be determined. We propose "myofibroblast phagocytic cutaneous mucinosis" as a candidate name. In addition, our discoveries suggest that phagocytosis by myofibroblasts is not rare but rather is a common pathological phenomenon that has been undetected or unrecognized.
  • Yuma Horii, Michio Nakaya, Hiroki Ohara, Hiroaki Nishihara, Kenji Watari, Akiomi Nagasaka, Takeo Nakaya, Yuki Sugiura, Toshiaki Okuno, Tomoaki Koga, Akira Tanaka, Takehiko Yokomizo, Hitoshi Kurose
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology 34(6) 8749-8763 2020年5月8日  査読有り
    Leukotriene B4 receptor 1 (BLT1), a high-affinity G-protein-coupled receptor for leukotriene B4 (LTB4 ), is expressed on various inflammatory cells and plays critical roles in several inflammatory diseases. In myocardial infarction (MI), various inflammatory cells are known to be recruited to the infarcted area, but the function of BLT1 in MI is poorly understood. Here, we investigated the role of BLT1 in MI and the therapeutic effect of a BLT1 antagonist, ONO-4057, on MI. Mice with infarcted hearts showed increased BLT1 expression and LTB4 levels. BLT1-knockout mice with infarcted hearts exhibited attenuated leukocyte infiltration, proinflammatory cytokine production, and cell death, which led to reduced mortality and improved cardiac function after MI. Bone-marrow transplantation studies showed that BLT1 expressed on bone marrow-derived cells was responsible for the exacerbation of inflammation in infarcted hearts. Furthermore, ONO-4057 administration attenuated the inflammatory responses in hearts surgically treated for MI, which resulted in reduced mortality and improved cardiac function after MI. Our study demonstrated that BLT1 contributes to excessive inflammation after MI and could represent a new therapeutic target for MI.
  • 辻 賢太郎, 仁木 利郎, 大城 久, 柴原 純二, 廣田 由佳, 仲矢 丈雄, 河田 浩敏, 田中 亨, 福嶋 敬宜
    日本病理学会会誌 109(1) 385-385 2020年3月  
  • Kentaro Tsuji, Takeo Nakaya, Kentaro Ashizawa, Fumihiro Arai, Noriyoshi Fukushima, Akira Gomi, Shintaro Sugita, Tadashi Hasegawa, Akira Tanaka
    Pathology international 70(2) 123-125 2020年2月  査読有り
  • 仲矢 丈雄, 大城 久, 斎藤 匠, 佐久間 康成, 曽我部 将哉, 山本 真一, 辻 賢太郎, 仲矢 道雄, 遠藤 俊輔, 堀江 久永, 佐田 尚宏, 仁木 利郎, 田中 亨
    日本癌学会総会記事 78回 E-2106 2019年9月  
  • Kentaro Tsuji, Atsushi Ito, Shinsuke Kurokawa, Takeo Nakaya, Taichiro Yoshimoto, Hirotoshi Kawata, Mio Tamba-Sakaguchi, Noriyoshi Fukushima, Hisashi Oshiro
    Medicine 98(32) e16643 2019年8月  査読有り
    RATIONALE: Primary carcinosarcoma of the upper urinary tract is rare. Ureteral duplication is one of the most common urinary tract malformations. Additionally, the association between ureteral duplication and malignancy is unknown. To the best of our knowledge, no cases of malignant tumors diagnosed as carcinosarcoma with ureteral duplication have been reported. We herein report the case of a patient with carcinosarcoma of the ureteropelvic junction associated with incomplete ureteral duplication. PATIENT CONCERNS: A 60-year-old Japanese woman presented with painless gross hematuria. She had a history of total hysterectomy and chemotherapy for endometrioid carcinoma 5 years before. She had no history of occupational chemical exposure. DIAGNOSES: Radiographic imaging revealed right incomplete ureteral duplication, hydronephrosis, and a polypoid tumor in the ureteropelvic junction of the lower moiety of the right kidney. Urine cytology showed a small amount of degenerated atypical epithelial and nonepithelial cells. The transureteral biopsy specimen showed dysplastic urothelial cells and atypical myoid spindle cells. These findings were indefinite for malignancy. INTERVENTIONS: The patient underwent right nephroureterectomy. Pathological examination of the resected tumor showed a biphasic neoplasm composed of carcinomatous and sarcomatous components. The sarcomatous component was immunohistochemically positive for vimentin, desmin, h-caldesmon, and α-SMA and negative for pancytokeratin (AE1/AE3), low molecular weight cytokeratin (CAM 5.2), EMA, E-cadherin, GATA3, uroplakin 2, and p63. Based on these findings, we diagnosed the tumor as carcinosarcoma. OUTCOMES: The postoperative course was uneventful. No additional therapy was administered. The patient has remained alive without recurrence for 21 months since surgery. LESSONS: Carcinosarcoma can arise from ureteral duplication. Although the majority of carcinosarcomas of the upper urinary tract are diagnosed at an advanced stage and have a poor prognosis, some can have a less aggressive course. Further studies are needed to determine the association between ureteral duplication and malignancy.
  • Takeo Nakaya, Masaya Sogabe, Shin-Ichi Yamamoto, Kentaro Tsuji, Michio Nakaya, Toshiro Niki, Shunsuke Endo, Akira Tanaka
    Medicine 98(24) e15888 2019年6月  査読有り
    RATIONALE: Suppression and of cancer metastasis is one of the most important issues in cancer care. Considering the typical clinical course of metastases, cancer cells might prefer certain environments or conditions. However, favorable environments for cancer metastasis have not been clearly identified. We had previously described a case of dual, yet separate, pancreatic and colon cancer, in which the metastatic pancreatic cancer was localized at the invasive portion of the colon cancer. We hypothesized that metastatic pancreatic cancer took over the colon cancer microenvironment. PATIENT CONCERNS: We experienced an another case of double cancer in a 65-year-old man who had lung squamous cell carcinoma and an independent pancreatic adenocarcinoma that metastasized to the liver as well as to the lung cancer lesion and pulmonary fibrotic regions associated with pneumothorax and bronchiolization. INTERVENTIONS: The pneumothorax could not be controlled by conservative treatment. Thus, an emergency surgery with partial resection of the lower lobe of right lung was performed. DIAGNOSES: We found multiple pancreatic cancer metastases in the lung cancer and fibrotic lesions in the surgical specimen. However, we detected no metastasis in normal lung tissues except inside small arteries, although the lung cancer and fibrotic tissue areas were smaller than the normal lung tissue areas in the surgical specimen. OUTCOMES: The patient died 50 days after the surgery. LESSONS: This case may thus provide evidence to strengthen our hypothesis that pancreatic cancer prefers to metastasize to other independent cancer lesions, overtaking the cancer microenvironment constructed by other independent cancers. The lung cancer microenvironment, rich in myofibroblasts and/or cancer-associated fibroblasts, might be suitable for pancreatic carcinoma metastasis. In addition, we propose the hypothesis that compared with normal tissues, noncancerous fibrotic lesions are preferable destinations for cancer metastasis. Furthermore, metastasis of pancreatic carcinoma to lung cancer and fibrotic tissues might be more common, although such cases have not been previously reported.
  • 仲矢 丈雄, 大城 久, 斎藤 匠, 佐久間 康成, 堀江 久永, 佐田 尚宏, 田中 亨
    日本病理学会会誌 108(1) 303-303 2019年4月  
  • Fujimoto Y, Takahashi H, Horie K, Nakaya T, Niki T, Fujiwara H, Matsubara S
    Case Rep Obstet Gynecol. 2019 3120921 2019年  査読有り
  • Nakaya T, Oshiro H, Saito T, Sakuma Y, Horie H, Sata N, Tanaka A
    Int J Clin Exp Pathol. 11(6) 3141-3146 2018年  査読有り
  • Naomi Nakano, Takeo Nakaya, Koji Kamiya, Mayumi Komine, Satoru Murata, Hirotoshi Kawata, Shigeo Yokoyama, Akira Tanaka, Mamitaro Ohtsuki
    JOURNAL OF DERMATOLOGY 44(11) 1327-1328 2017年11月  査読有り
  • Takeo Nakaya, Taiju Hyuga, Yukichi Tanaka, Shina Kawai, Hideo Nakai, Toshiro Niki, Akira Tanaka
    MEDICINE 96(15) e6499 2017年4月  査読有り
  • 廣澤 拓也, 森本 直樹, 三浦 光一, 渡邊 俊司, 津久井 舞未子, 村山 梢, 高岡 良成, 野本 弘章, 仲矢 丈雄, 大城 久, 礒田 憲夫, 山本 博徳
    肝臓 58(10) 567-573 2017年  
    <p>症例は39歳男性.37歳時に食道静脈瘤破裂で他院入院の際,両側肺門リンパ節腫脹および肺野粒状影を認め,リンパ節生検で非乾酪性肉芽腫を認めたため,肺サルコイドーシスの診断となった.食道静脈瘤のフォローアップと門脈圧亢進症の原因精査目的に当科紹介となった.腹腔鏡検査では肝表面は広範に凹凸不整で辺縁は鈍であった.また肝表面には粒状の白色結節が多数見られ,肝辺縁で一部癒合し斑状であった.同時に施行した肝生検では,非乾酪性肉芽腫を認め,肝表面の所見と合わせて,肝サルコイドーシスの診断に至った.肉芽腫は門脈域に認めており,門脈の壁外性圧迫や閉塞により門脈圧亢進症を来したと推定された.ステロイドによる加療を開始し,1年近く経過しているが,肝障害は軽度改善し,食道静脈瘤は増悪なく経過している.肝サルコイドーシスに門脈圧亢進症を合併することは稀であり,腹腔鏡検査にて合併症なく診断できたので報告する.</p>
  • Hirotoshi Kawata, Tomoko Kamiakito, Takeo Nakaya, Maiko Komatsubara, Kenji Komatsu, Tatsuo Morita, Yasumitsu Nagao, Akira Tanaka
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY 165(Pt B) 219-227 2017年1月  査読有り
  • Michio Nakaya, Kenji Watari, Mitsuru Tajima, Takeo Nakaya, Shoichi Matsuda, Hiroki Ohara, Hiroaki Nishihara, Hiroshi Yamaguchi, Akiko Hashimoto, Mitsuho Nishida, Akiomi Nagasaka, Yuma Horii, Hiroki Ono, Gentaro Iribe, Ryuji Inoue, Makoto Tsuda, Kazuhide Inoue, Akira Tanaka, Masahiko Kuroda, Shigekazu Nagata, Hitoshi Kurose
    JOURNAL OF CLINICAL INVESTIGATION 127(1) 383-401 2017年1月  査読有り
  • Nakaya T, Oshiro H, Takigami A, Kanai Y, Tetsuka K, Hagiwara K, Fujii H, Endo S, Tanaka A
    Medicine 96(50) e8926 2017年  査読有り
  • Takeo Nakaya, Shuichiro Kobayashi, Satoshi Kitahara, Akira Tanaka, Hiroshi Kamma, Akio Komatsu
    Human Pathology: Case Reports 5 29-33 2016年9月1日  査読有り
  • Hisashi Oshiro, Masahiro Miura, Hiroaki Iobe, Tomoo Kudo, Yoshihito Shimazu, Takaaki Aoba, Koji Okudela, Kiyotaka Nagahama, Kentaro Sakamaki, Maki Yoshida, Toshitaka Nagao, Takeo Nakaya, Atsushi Kurata, Osamu Ohtani
    Lymphatic research and biology 13(2) 137-45 2015年6月  査読有り
    BACKGROUND: Lymphatic stomata are small lymphatic openings in the serosal membrane that communicate with the serosal cavity. Although these stomata have primarily been studied in experimental mammals, little is known concerning the presence and properties of lymphatic stomata in the adult human pleura. Thus, adult human pleurae were examined for the presence or absence of lymphatic stomata. METHODS AND RESULTS: A total of 26 pulmonary ligaments (13 left and 13 right) were obtained from 15 adult human autopsy cases and examined using electron and light microscopy. The microscopic studies revealed the presence of apertures fringed with D2-40-positive, CD31-positive, and cytokeratin-negative endothelial cells directly communicating with submesothelial lymphatics in all of the pulmonary ligaments. The apertures' sizes and densities varied from case to case according to the serial tissue section. The medians of these aperture sizes ranged from 2.25 to 8.75 μm in the left pulmonary ligaments and from 2.50 to 12.50 μm in the right pulmonary ligaments. The densities of the apertures ranged from 2 to 9 per mm(2) in the left pulmonary ligaments and from 2 to 18 per mm(2) in the right pulmonary ligaments. However, no significant differences were found regarding the aperture size (p=0.359) and density (p=0.438) between the left and the right pulmonary ligaments. CONCLUSIONS: Our study revealed that apertures exhibit structural adequacy as lymphatic stomata on the surface of the pulmonary ligament, thereby providing evidence that lymphatic stomata are present in the adult human pleura.
  • Takeo Nakaya, Kiyoko Morita, Atsushi Kurata, Tetsuo Ushiku, Takashi Igarashi, Masahiko Kuroda, Masashi Fukayama
    HUMAN PATHOLOGY 45(8) 1773-1777 2014年8月  査読有り
  • Camille Belzil, Naoyuki Asada, Kei-ichiro Ishiguro, Takeo Nakaya, Kari Parsons, Valentina Pendolino, Gernot Neumayer, Marina Mapelli, Yoshihiro Nakatani, Kamon Sanada, Minh Dang Nguyen
    BIOLOGY OPEN 3(6) 475-485 2014年6月  査読有り
  • Takeo Nakaya, Seishi Ogawa, Ichiro Manabe, Masami Tanaka, Masashi Sanada, Toshiro Sato, Makoto M. Taketo, Kazuki Nakao, Hans Clevers, Masashi Fukayama, Masahiko Kuroda, Ryozo Nagai
    CANCER RESEARCH 74(10) 2882-2891 2014年5月  査読有り
  • Takeo Nakaya, Atsushi Kurata, Hirotsugu Hashimoto, Shigeo Nishimata, Yasuyo Kashiwagi, Koji Fujita, Hisashi Kawashima, Masahiko Kuroda
    PATHOLOGY INTERNATIONAL 64(2) 75-80 2014年2月  査読有り
  • Takeo Nakaya, Kei-ichiro Ishiguro, Camille Belzil, Anna M. Rietsch, Qunyan Yu, Shin-ichi Mizuno, Roderick T. Bronson, Yan Geng, Minhng Da Nguyen, Koichi Akashi, Piotr Sicinski, Yoshihiro Nakatani
    PLoS ONE 8(6) e66269 2013年6月18日  査読有り
  • Takeo Nakaya, Yoshinao Kikuchi, Akiko Kunita, Shumpei Ishikawa, Keisuke Matsusaka, Rumi Hino, Hiroyuki Aburatani, Masashi Fukayama
    VIRUS RESEARCH 174(1-2) 108-115 2013年6月  査読有り
  • Michio Nakaya, Mitsuru Tajima, Hidetaka Kosako, Takeo Nakaya, Akiko Hashimoto, Kenji Watari, Hiroaki Nishihara, Mina Ohba, Shiori Komiya, Naoki Tani, Motohiro Nishida, Hisaaki Taniguchi, Yoji Sato, Mitsuru Matsumoto, Makoto Tsuda, Masahiko Kuroda, Kazuhide Inoue, Hitoshi Kurose
    NATURE COMMUNICATIONS 4 1532 2013年2月  査読有り
  • 仲矢 丈雄, 菊地 良直, 松坂 恵介, 石川 俊平, 日野 るみ, 坂谷 貴司, 油谷 浩幸, 深山 正久
    日本病理学会会誌 99(1) 196-196 2010年3月  査読有り
  • 仲矢 丈雄, 菊地 良直, 石川 俊平, 松坂 恵介, 日野 るみ, 坂谷 貴司, 油谷 浩幸, 深山 正久
    日本癌学会総会記事 68回 76-77 2009年8月  査読有り
  • Rumi Hino, Hiroshi Uozaki, Noriko Murakami, Tetsuo Ushiku, Aya Shinozaki, Shumpei Ishikawa, Teppei Morikawa, Takeo Nakaya, Takashi Sakatani, Kenzo Takada, Masashi Fukayama
    CANCER RESEARCH 69(7) 2766-2774 2009年4月  査読有り
  • T Nakaya, M Sato, N Hata, M Asagiri, H Suemori, S Noguchi, N Tanaka, T Taniguchi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 283(5) 1150-1156 2001年5月  査読有り
  • M Sato, H Suemori, N Hata, M Asagiri, K Ogasawara, K Nakao, T Nakaya, M Katsuki, S Noguchi, N Tanaka, T Taniguchi
    IMMUNITY 13(4) 539-548 2000年10月  査読有り
  • M Sato, N Hata, M Asagiri, T Nakaya, T Taniguchi, N Tanaka
    FEBS LETTERS 441(1) 106-110 1998年12月  査読有り

MISC

 3

書籍等出版物

 4

講演・口頭発表等

 4

担当経験のある科目(授業)

 1

共同研究・競争的資金等の研究課題

 11